Arvind Remedies has signed a Memorandum of Understanding (MoU) with four institutions namely Banaras Hindu University (BHU) Varanasi, Adesh University, SRM University and Genome Foundation to the manufacture and market medicines from botanical source. Under the agreement, Arvind Remedies and the institutions together have developed and patented medicines which are useful for the treatment and management of neurodegeneration disorder (like alzheimer’s, parkinson’s disease) and neuropsychiatric disorders (like depression). The said medicines have been patented in India, US and Europe.
The event at BHU was attended by institutional officials like Dr Lalji Singh, Managing Director, Genome Foundation and the Vice Chancellor of BHU, Prof GS Yadav, Registrar of the University, Anand Shah, Vice President, Arvind Remedies, (Lt Col) GPI Singh, Vice Chancellor of Adesh University, and Ponnawaiko, Vice Chancellor of SRM University, Tamil Nadu.
The agreement was signed by the four institutions in December 2012, to do the research from their respective fields and since then continuous research and developmental activiites were taking place.
Dr Arvind B Shah, Managing Director and Chief Executive Officer, Arvind Remedies said, “We are excited about the MoU as it will help us to enhance our product portfolio and also improve our revenue in the near future.”
GP Dubey said, “The modern medicines have side effects, but medicines from botanical source are not only economical but are free from side effects.”
EP News bureau – Mumbai
